ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
ARTV
47 hedge funds and large institutions have $27.9M invested in Artiva Biotherapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 17 closing their positions.
Holders
47
Holders Change
-6
Holders Change %
-11.32%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
9
Reduced
15
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$494K |
| 2 |
HF
2
HRT Financial
New York
|
$117K |
| 3 |
3
Goldman Sachs
New York
|
$178K |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$78.8K |
| 5 |
5
Jane Street
New York
|
$66.8K |
